WEE1 and acute myeloid leukemia: More specifically, WEE1 and ATR inhibitors caused the synergistic killing of acute myeloid leukemia (AML), biliary tract, and breast cancer cells, likely due to problems arising in S-phase and G2/M [19,20,21,23].